AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Enanta Pharmaceuticals, Inc.

$10.71 -$3.71 (-25.73%)
NASDAQ · 30 Oct 2026 20:00 UTC
Previous Close
$11.15
Day Range
$10.71$11.17
Year Range
$10.22$17.15
Market Cap
311.93M
AVG Volume
237.43K
Trailing/Forward PE
-4.44/-
PEG ratio
1.08
Dividend Yield
-
Next Earnings Date
2026-11-16
Primary Exchange
NASDAQUS
Revenue (USD) · TTM
020M40M60M80M24 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q3
ENTA Revenue (USD) by quarter, trailing twelve months
PeriodRevenue (USD)
26 Q365.26M
26 Q269.21M
26 Q166.98M
25 Q465.32M
25 Q364.81M
25 Q264.46M
25 Q166.59M
24 Q467.64M
24 Q371.96M
24 Q272.88M
Net Income (USD) · TTM
-150M-100M-50M024 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q3
ENTA Net Income (USD) by quarter, trailing twelve months
PeriodNet Income (USD)
26 Q3-63.23M
26 Q2-61.98M
26 Q1-71.54M
25 Q4-81.89M
25 Q3-92.01M
25 Q2-96.42M
25 Q1-104.93M
24 Q4-116.05M
24 Q3-115.33M
24 Q2-131.74M
Operating Income (USD) · TTM
-150M-100M-50M024 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q3
ENTA Operating Income (USD) by quarter, trailing twelve months
PeriodOperating Income (USD)
26 Q3-58.73M
26 Q2-60.38M
26 Q1-73.06M
25 Q4-85.35M
25 Q3-96.82M
25 Q2-102.11M
25 Q1-110.35M
24 Q4-121.69M
24 Q3-122.87M
24 Q2-135.4M
EBITDA · TTM
Cash Flows · TTM
EPS · TTM
Expenses · TTM
Cash & Debt · TTM
Debt ratios · TTM
Margins · TTM
Return on Capital · TTM
Shares Outstanding · TTM
Dividends (USD) · TTM
Employee Count
Book Value Per Share · TTM
Total Assets · TTM
PE Ratio
Free Cash Flow Yield
Price to Sales
EV/EBITDA
Price/Operating Cashflow
Price to Book

Earnings: ENTA

Estimate against actual revenue and earnings per share, the beat and miss record of recent reports, and how the price moved around each one. Next report: 16 Nov 2026.

Enanta Pharmaceuticals, Inc.
ENTA
Stockpicker

Video analysis: ENTA

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

News: ENTA

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.